机构:[1]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China神经科系统神经内科首都医科大学宣武医院[2]Department of Neurology, Beijing Shijitan hospital, Capital Medical University, Beijing, China[3]Beijing Key Laboratory of Hypoxia Conditioning Translational Medicine, Xuan Wu Hospital, Capital Medical University, Beijing, China首都医科大学宣武医院[4]Department of Neurosurgery, Beijing Fengtai You'anmen Hospital, Beijing, China[5]Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China北京朝阳医院[6]Department of Neurosurgery, Xuan Wu Hospital, Capital Medical University, Beijing, China神经科系统神经外科首都医科大学宣武医院
AimsThe significance of the correlation of computed tomography (CT)-based cerebral small vessel disease (SVD) markers with the clinical outcomes in patients with cerebral amyloid angiopathy (CAA)-related intracerebral hemorrhage (ICH) remains uncertain. Thus, this study aimed to explore the relationship between SVD markers and short-term outcomes of CAA-ICH. MethodsA total of 183 patients with CAA-ICH admitted to the Xuanwu Hospital, and Beijing Fengtai You'anmen Hospital, from 2014 to 2021 were included. The multivariate logistic regression analysis was performed to identify the correlation between SVD markers based on CT and clinical outcomes at 7-day and 90-day. ResultsOf the 183 included patients, 66 (36%) were identified with severe SVD burden. The multivariate analysis showed that the total SVD burden, white matter lesion (WML) grade, and brain atrophy indicator were independent risk factors for unfavorable outcomes at 90-day. The brain atrophy indicator was independently associated with mortality at 90-day. Severe cortical atrophy was significantly associated with early neurological deterioration. ConclusionsThe neuroimaging profiles of SVD based on CT in patients with CAA-ICH might predict the short-term outcome more effectively. Further studies are required to validate these findings and identify modifiable factors for preventing CAA-ICH development.
基金:
National Natural Science Foundation of
China, Grant/Award Number: 82001257,
82027802 and 81971114
第一作者机构:[1]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China
共同第一作者:
通讯作者:
通讯机构:[3]Beijing Key Laboratory of Hypoxia Conditioning Translational Medicine, Xuan Wu Hospital, Capital Medical University, Beijing, China[6]Department of Neurosurgery, Xuan Wu Hospital, Capital Medical University, Beijing, China[*1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No 45, Changchun Street, Xicheng District, Beijing 100053, China.
推荐引用方式(GB/T 7714):
Zhang Mengke,Che Ruiwen,Zhao Wenbo,et al.Neuroimaging biomarkers of small vessel disease in cerebral amyloid angiopathy-related intracerebral hemorrhage[J].CNS NEUROSCIENCE & THERAPEUTICS.2023,29(5):1222-1228.doi:10.1111/cns.14098.
APA:
Zhang, Mengke,Che, Ruiwen,Zhao, Wenbo,Sun, Hailiang,Ren, Changhong...&Ji, Xunming.(2023).Neuroimaging biomarkers of small vessel disease in cerebral amyloid angiopathy-related intracerebral hemorrhage.CNS NEUROSCIENCE & THERAPEUTICS,29,(5)
MLA:
Zhang, Mengke,et al."Neuroimaging biomarkers of small vessel disease in cerebral amyloid angiopathy-related intracerebral hemorrhage".CNS NEUROSCIENCE & THERAPEUTICS 29..5(2023):1222-1228